MyHealthChecked PLC is a United Kingdom-based consumer home-testing healthcare company. The Company is the umbrella brand of a range of at-home rapid tests, as well as deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and blood sample collection kits. The Company also provides COVID tests. The Company's multi-platform portfolio of tests offers users access to a variety of test types, sample collection options, and levels of analysis, enabling it to meet diverse customer needs.
The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analyzed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. All its business activity is underpinned by two distinct routes to market: business to business to consumer (B2B2C) and direct to consumer..
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 87.8K |
| Three Month Average Volume | 1.6M |
| High Low | |
| Fifty-Two Week High | 0.16 GBX |
| Fifty-Two Week Low | 0.08 GBX |
| Fifty-Two Week High Date | 04 Jan 2024 |
| Fifty-Two Week Low Date | 07 Aug 2024 |
| Price and Volume | |
| Current Price | 0.1125 GBX |
| Beta | 2 |
| Relative Price Change | |
| Four Week Relative Price Change | 18.90% |
| Thirteen Week Relative Price Change | -2.39% |
| Twenty-Six Week Relative Price Change | -22.14% |
| Fifty-Two Week Relative Price Change | -0.21% |
| Year-to-Date Relative Price Change | -21.49% |
| Price Change | |
| One Day Price Change | 2.27% |
| Thirteen Week Price Change | -1.10% |
| Twenty-Six Week Price Change | -15.09% |
| Five Day Price Change | 2.27% |
| Fifty-Two Week Price Change | 12.50% |
| Year-to-Date Price Change | -15.09% |
| Month-to-Date Price Change | 18.42% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 0.16737 GBX |
| Book Value Per Share (Most Recent Quarter) | 0.16737 GBX |
| Tangible Book Value Per Share (Last Fiscal Year) | 0.13925 GBX |
| Tangible Book Value Per Share (Most Recent Quarter) | 0.13925 GBX |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -0.00046 GBX |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 0.21107 GBX |
| Revenue Per Share (Trailing Twelve Months) | 0.21107 GBX |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 GBX |
| Dividend Per Share (Trailing Twelve Months) | 0 GBX |
| Dividend Per Share (5 Year) | -99999.99 GBX |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -0.00306 GBX |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.00305 GBX |
| Normalized (Last Fiscal Year) | -0.00163 GBX |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.00306 GBX |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.00305 GBX |
| Including Extraordinary Items (Last Fiscal Year) | -0.00306 GBX |
| Including Extraordinary Items (Trailing Twelve Months) | -0.00305 GBX |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.149 GBX |
| Cash Per Share (Most Recent Quarter) | 0.149 GBX |
| Cash Flow Per Share (Last Fiscal Year) | 0.00123 GBX |
| Cash Flow Per Share (Trailing Twelve Months) | 0.00123 GBX |
| Free Cash Flow Per Share (Trailing Twelve Months) | 0.00371 GBX |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | 0 |
| Cash Flow Revenue (Trailing Twelve Months) | 2 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -1.78% |
| Pretax Margin (Last Fiscal Year) | -1.78% |
| Pretax Margin (5 Year) | -5.89% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 18.66% |
| Gross Margin (Trailing Twelve Months) | 18.66% |
| Gross Margin (5 Year) | 22.82% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -3.29% |
| Operating Margin (Trailing Twelve Months) | -3.29% |
| Operating Margin (5 Year) | -6.16% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -1.45% |
| Net Profit Margin (Trailing Twelve Months) | -1.45% |
| Net Profit Margin (5 Year) | -5.13% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -0.04% |
| Tangible Book Value (5 Year) | 35.34% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -31.80% |
| Revenue Growth (3 Year) | 368.95% |
| Revenue Change (Trailing Twelve Months) | -50.81% |
| Revenue Per Share Growth | 240.89% |
| Revenue Growth (5 Year) | 505.36% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -2.00% |
| Total Debt (5 Year) | -38.33% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -68.70% |
| EPS Change (Trailing Twelve Months) | -110.58% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 1 |
| Price to Tangible Book (Most Recent Quarter) | 1 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | 30 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 30 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -7,723,000 |
| Net Debt (Last Fiscal Year) | -7,723,000 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 1 |
| Price to Sales (Trailing Twelve Months) | 1 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 45 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 4 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 1 |
| Price to Book (Most Recent Quarter) | 1 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 0 |
| Long Term Debt to Equity (Most Recent Quarter) | 0 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 2 |
| Quick Ratio (Most Recent Quarter) | 2 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 3 |
| Current Ratio (Most Recent Quarter) | 3 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | 193.0K |
| Free Cash Flow (Trailing Twelve Months) | 193.0K |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -100,000 |
| Net Interest Coverage (Trailing Twelve Months) | -100,000 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 0 |
| Total Debt to Equity (Most Recent Quarter) | 0 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -1.28% |
| Return on Assets (Trailing Twelve Months) | -1.28% |
| Return on Assets (5 Year) | -7.24% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -1.81% |
| Return on Equity (Trailing Twelve Months) | -1.81% |
| Return on Equity (5 Year) | -10.57% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -1.81% |
| Return on Investment (Trailing Twelve Months) | -1.81% |
| Return on Investment (5 Year) | -10.39% |